DE60007745D1 - Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe - Google Patents

Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Info

Publication number
DE60007745D1
DE60007745D1 DE60007745T DE60007745T DE60007745D1 DE 60007745 D1 DE60007745 D1 DE 60007745D1 DE 60007745 T DE60007745 T DE 60007745T DE 60007745 T DE60007745 T DE 60007745T DE 60007745 D1 DE60007745 D1 DE 60007745D1
Authority
DE
Germany
Prior art keywords
heterocyclic
agents
melatoninergic
aminopyrrolidone derivatives
aminopyrrolidone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60007745T
Other languages
English (en)
Other versions
DE60007745T2 (de
Inventor
S Takaki
Guanglin Luo
R Bertenshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DE60007745D1 publication Critical patent/DE60007745D1/de
Application granted granted Critical
Publication of DE60007745T2 publication Critical patent/DE60007745T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
DE60007745T 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe Expired - Lifetime DE60007745T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14189499P 1999-06-30 1999-06-30
US141894P 1999-06-30
PCT/US2000/015478 WO2001002392A1 (en) 1999-06-30 2000-06-06 Heterocyclic aminopyrrolidine derivatives as melatonergic agents

Publications (2)

Publication Number Publication Date
DE60007745D1 true DE60007745D1 (de) 2004-02-19
DE60007745T2 DE60007745T2 (de) 2005-03-10

Family

ID=22497702

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60007745T Expired - Lifetime DE60007745T2 (de) 1999-06-30 2000-06-06 Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe

Country Status (13)

Country Link
US (1) US6211225B1 (de)
EP (1) EP1189900B1 (de)
JP (2) JP4767463B2 (de)
AT (1) ATE257834T1 (de)
AU (1) AU763963B2 (de)
CA (1) CA2376949C (de)
DE (1) DE60007745T2 (de)
DK (1) DK1189900T3 (de)
ES (1) ES2213022T3 (de)
PE (1) PE20010327A1 (de)
PT (1) PT1189900E (de)
UY (1) UY26226A1 (de)
WO (1) WO2001002392A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569894B1 (en) 2001-10-04 2003-05-27 Bristol-Myers Squibb Company Arylalkylbenzofuran derivatives as melatonergic agents
US6737431B2 (en) 2002-03-12 2004-05-18 Bristol-Myers Squibb Company Benzoxazole derivatives as novel melatonergic agents
AU2003254993A1 (en) * 2002-08-12 2004-03-03 Takeda Pharmaceutical Company Limited Fused benzene derivative and use
TW200719886A (en) * 2005-04-22 2007-06-01 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
EP1871754A1 (de) * 2005-04-22 2008-01-02 Wyeth a Corporation of the State of Delaware Dihydrobenzofuran-derivate und verwendungen dafür
JP2009538334A (ja) * 2006-05-22 2009-11-05 ヴァンダ ファーマシューティカルズ インコーポレイテッド 抑うつ障害のための治療
KR20100017297A (ko) * 2007-04-26 2010-02-16 다케다 야쿠힌 고교 가부시키가이샤 ２환식 화합물 및 이의 약학적 용도
ES2331276B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuestos de fenilpirrolidina.
EP2266975A1 (de) * 2009-06-15 2010-12-29 Ferrer Internacional, S.A. 1-(2-Alkyl-2,3-dihydrobenzofuran-4-yl)pyrrolidin-3-ylaminacyl-Verbindungen
ES2646197T3 (es) 2012-01-26 2017-12-12 Vanda Pharmaceuticals Inc. Tratamiento de trastornos del ritmo circadiano
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2681593T3 (es) 2012-11-29 2018-09-14 Chemocentryx, Inc. Antagonistas de CXCR7
IL266159B1 (en) 2012-12-18 2024-03-01 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono
US11464786B2 (en) 2018-12-12 2022-10-11 Chemocentryx, Inc. CXCR7 inhibitors for the treatment of cancer
CN109574970A (zh) * 2018-12-27 2019-04-05 上海毕得医药技术有限公司 一种5-溴苯并二氢吡喃的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518273A (en) * 1966-08-03 1970-06-30 Warner Lambert Pharmaceutical Benzopyranquinolinol derivatives and process for their production
US3485835A (en) * 1968-04-10 1969-12-23 Haessle Ab 2-benzoyl-3-tertiaryamino alkoxy benzofuran derivatives
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2674524B1 (fr) 1991-03-25 1993-05-21 Adir Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680366B1 (fr) 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5449683A (en) 1992-10-01 1995-09-12 Massachussetts Institute Of Technology Methods of inducing sleep using melatonin
GB9326192D0 (en) 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9407919D0 (en) 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds
FR2725985B1 (fr) 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5753709A (en) 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
DE69723436T2 (de) 1996-05-14 2004-07-22 Glaxo Group Ltd., Greenford Benzofurane und benzpyrane als chronobiologische mittel
PT1027043E (pt) * 1996-12-10 2005-02-28 Bristol Myers Squibb Co Benzodioxole benzofurano di-hidrobenzofurano e benzodioxano como agentes melatonergicos
FR2761358B1 (fr) * 1997-03-27 1999-05-07 Adir Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2213022T3 (es) 2004-08-16
PE20010327A1 (es) 2001-06-10
CA2376949C (en) 2009-05-26
AU763963B2 (en) 2003-08-07
US6211225B1 (en) 2001-04-03
JP4767463B2 (ja) 2011-09-07
JP2011137043A (ja) 2011-07-14
DK1189900T3 (da) 2004-04-26
WO2001002392A1 (en) 2001-01-11
EP1189900B1 (de) 2004-01-14
AU5324000A (en) 2001-01-22
EP1189900A4 (de) 2002-07-31
EP1189900A1 (de) 2002-03-27
CA2376949A1 (en) 2001-01-11
PT1189900E (pt) 2004-05-31
JP2003503492A (ja) 2003-01-28
UY26226A1 (es) 2001-01-31
ATE257834T1 (de) 2004-01-15
DE60007745T2 (de) 2005-03-10
JP5248647B2 (ja) 2013-07-31

Similar Documents

Publication Publication Date Title
DE60007745D1 (de) Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
TR199901674T2 (de)
ATE245636T1 (de) Benzofurylpiperazine: 5-ht2c serotoninrezeptor agonisten
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
ATE323678T1 (de) Tri-aryl-säurederivate als ppar rezeptor liganden
DE60110262D1 (de) Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
DE69906940T2 (de) Bizyclische pyrrolverbindungen, deren pharmazeutische zusammensetzungen und ihre verwendung als entzündungshemmende und immunmodulierende mittel
EA200300064A1 (ru) Карбоксамидные соединения и их применение в качестве антагонистов 11cby-рецептора человека
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
SE9702773D0 (sv) Novel compounds
ES2191076T3 (es) Nuevos derivados de 1-aril-pirazol y su empleo como plaguicidas.
CO5271666A1 (es) Derivados de pirimidina
TR199903277T2 (xx) Benzimidazol t�revleri.
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DE60139382D1 (de) 2-hydroxy-mutilin-carbamat derivate und ihre anwendung als antibakterielle mittel
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
DE69528983D1 (de) Indolalkaloide als antientzündliche wirkstoffe
SE9904674D0 (sv) Novel compounds
DE60112960D1 (de) Kondensierte pyridoindolderivate
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
CY1105373T1 (el) Ισοκινολινυλικα καρβοξαμιδια και η χρηση τους ως αντισπαστικα
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
CO5261576A1 (es) Compuestos
ATE207460T1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition